Role of Stent Insertion in Managing Obstructive Symptoms in Gastric Cancer
Endoscopic placement of self-expanding metal stents (SEMS) is a safe, effective, and minimally invasive palliative treatment for patients with luminal obstruction due to advanced gastric cancer, particularly for those with shorter life expectancy. 1
Patient Selection for Stent Placement vs. Surgical Bypass
The choice between stent placement and surgical intervention should be guided by the patient's prognosis:
For patients with shorter life expectancy: SEMS placement is preferred due to:
For patients with longer life expectancy: Gastrojejunostomy may be preferable due to:
Benefits of Stent Placement
- Technical success rates of approximately 98% 2
- Clinical success rates of approximately 84% 2
- Significant improvement in gastric outlet obstruction scoring system 2
- Median stent patency of 307 days in some studies 2
- Can be combined with chemotherapy for patients with good performance status 3, 4
Potential Complications and Management
Tumor ingrowth/overgrowth:
Stent migration:
Pain after stent placement:
Alternative Approaches for Obstruction Management
When stent placement is not feasible or unsuccessful:
Surgical options:
Non-surgical alternatives:
When obstruction cannot be alleviated:
Comprehensive Approach to Symptom Management
Beyond addressing obstruction, management should include:
Pain control:
Nausea and vomiting:
Nutritional support:
Integration with Other Treatment Modalities
- Stent placement can be safely combined with chemotherapy for patients with good performance status 3, 4
- No significant differences in survival, time to treatment failure, or response rates between surgery plus chemotherapy versus stenting plus chemotherapy 4
- A multidisciplinary approach involving endoscopists, surgeons, oncologists, and interventional radiologists is essential for optimal outcomes 6